Islamic State attack on Iraq's Kirkuk rebuffedWorld October 21, 15:48
Romano Prodi says Nord Stream 2 gas pipeline is not in Italy’s interestBusiness & Economy October 21, 15:38
Russian women's futsal team 'didn't have to wear hijabs, but chose to' — coachSport October 21, 15:35
Moscow says Belgian defense minister tries to distract attention from Hassadjek attackRussian Politics & Diplomacy October 21, 15:04
Russian suspected of alleged cyberattacks on US to remain in custody — Czech ministryWorld October 21, 14:55
Justice Ministry rejects Ukraine’s extradition bid for filmmaker convicted in terror plotRussian Politics & Diplomacy October 21, 14:52
Kremlin says EU sanctions policy against Russia destructiveRussian Politics & Diplomacy October 21, 14:48
NATO to use AWACS aircraft for Syrian airspace surveillance soonWorld October 21, 14:40
Switzerland seeks to bolster ties with Russia — senior lawmakerRussian Politics & Diplomacy October 21, 14:26
MOSCOW, October 29. /TASS/. The Federal Antimonopoly Service (FAS) wants to introduce a simplified procedure for admission of medicines, previously registered in the US and Europe to Russia, the head of FAS Igor Artemyev said on Thursday speaking at a cabinet session.
"It is necessary to check the history [of these medicines]. This system should not be automatic, we have to check, but if it was registered in the United States or Europe, there must be a simplified procedure for the introduction of these medicines in the Russian Federation," he said.
Artemyev also said that in the next five years a new section for the development of competition in the healthcare sector should be added to the competition development program.
"It is necessary to add an aspect about the sale of medicines via retail chains there. I would say that the issue of substitution should be solved not by 2018 but by 2017. This will have a significant effect on prices and improve competition in healthcare sector," he said.